UBS Reiterates Buy Rating on Surgery Partners (SGRY) Following Activist Letter to Shareholders
Tweet Send to a Friend
UBS analyst AJ Rice reiterated a Buy rating and $21.00 price target on Surgery Partners (NASDAQ: SGRY).The analyst commented, "At ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
